| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/08/2014 | CA2641575C Stabilization of solid thyroid drug formulations |
| 04/08/2014 | CA2623848C Topical anesthetic for dental procedures |
| 04/08/2014 | CA2605773C Stable emulsion composition |
| 04/08/2014 | CA2558219C Poorly water-soluble drug-containing solid formulation |
| 04/03/2014 | WO2014052961A1 Pvax copolymer and pvax microparticles comprising the same |
| 04/03/2014 | WO2014052875A1 Stimulus-sensitive microparticles and methods of use |
| 04/03/2014 | WO2014052837A1 Device and methods for sustained release of antipsychotic medications |
| 04/03/2014 | WO2014052678A1 Apixaban liquid formulations |
| 04/03/2014 | WO2014052634A1 Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof |
| 04/03/2014 | WO2014052518A1 Biodegradable drug delivery systems for the sustained release of proteins |
| 04/03/2014 | WO2014052490A1 Methods of using fix polypeptides |
| 04/03/2014 | WO2014051442A1 Veterinary pharmaceutical formulations and methods |
| 04/03/2014 | WO2014051251A1 Pvax copolymer and pvax microparticles comprising the same |
| 04/03/2014 | WO2014051163A1 Pharmaceutical composition comprising rebamipide |
| 04/03/2014 | WO2014051128A1 Transdermal patch |
| 04/03/2014 | WO2014051025A1 Anagliptin-containing solid preparation |
| 04/03/2014 | WO2014051023A1 Anagliptin-containing preparation |
| 04/03/2014 | WO2014051022A1 Fgfr3 fusion gene and pharmaceutical drug targeting same |
| 04/03/2014 | WO2014050912A1 Liquid medicine having carbon dioxide dissolved therein, and therapeutic method using same |
| 04/03/2014 | WO2014050852A1 Ointment for mucosal application |
| 04/03/2014 | WO2014050851A1 Oral liquid composition |
| 04/03/2014 | WO2014050509A1 Liposome and liposome preparation |
| 04/03/2014 | WO2014050301A1 Aqueous liquid medicine |
| 04/03/2014 | WO2014049532A2 Conjugate of a fragment of a cellular wall of a bacterium and a mucopolysaccharidic carrier, and uses in medicine thereof |
| 04/03/2014 | WO2014049300A1 Topical use of laropiprant for the treatment of rosacea |
| 04/03/2014 | WO2014049112A1 Liquid concentrated vitamin e compositions |
| 04/03/2014 | WO2014049073A1 Test for hemolytic potential of pharmaceutical products and formulations for risk minimization |
| 04/03/2014 | WO2014049071A1 Modulators of androgen synthesis |
| 04/03/2014 | WO2014048996A1 Colloid bonded medicinal compounds |
| 04/03/2014 | WO2014048977A1 Albumin binding polzpeptide |
| 04/03/2014 | WO2014048836A1 Stabilized aqueous compositions of neuromuscular blocking agents |
| 04/03/2014 | WO2014048507A1 Process for preparing aqueous dispersions |
| 04/03/2014 | WO2014048380A1 Preparation method of agomelatine solid preparation |
| 04/03/2014 | WO2014047731A1 Abuse deterrent pharmaceutical composition comprising konjac glucomannan |
| 04/03/2014 | WO2013092983A3 Enzymatic conjugation of polypeptides |
| 04/03/2014 | WO2013058758A3 Compounds, compositions, and methods for reducing or eliminating bitter taste |
| 04/03/2014 | WO2013057171A9 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii |
| 04/03/2014 | WO2012075083A3 Viscosity control in compositions comprising plant fiber materials |
| 04/03/2014 | US20140094529 Molecular containers and methods of making and using same |
| 04/03/2014 | US20140094528 Oil-based gel-like composition |
| 04/03/2014 | US20140094498 Methods and compositions for treating post-operative pain comprising clonidine |
| 04/03/2014 | US20140094478 Composition and tablet comprising raltegravir |
| 04/03/2014 | US20140094472 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| 04/03/2014 | US20140094463 Pharmaceutical Compositions |
| 04/03/2014 | US20140094439 pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME |
| 04/03/2014 | US20140094432 Methods and systems for polymer precipitation and generation of particles |
| 04/03/2014 | US20140094426 Amphiphile prodrugs |
| 04/03/2014 | US20140094418 Palatable ductile chewable veterinary composition |
| 04/03/2014 | US20140094410 Silk fibroin materials and use thereof |
| 04/03/2014 | US20140094407 Devices and methods for treating and/or preventing diseases |
| 04/03/2014 | US20140094399 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/03/2014 | US20140093594 Composition to Enhance the Bioavailability of Curcumin |
| 04/03/2014 | US20140093590 Bitter-taste inhibitor and ginseng composition comprising same |
| 04/03/2014 | US20140093580 Silk-based drug delivery system |
| 04/03/2014 | US20140093576 Pharmaceutical Dosage Form with Multiple Coatings for Reduced Impact of Coating Fractures |
| 04/03/2014 | US20140093559 Abuse-proofed dosage form |
| 04/03/2014 | US20140093546 Implants for administering substances and methods of producing implants |
| 04/03/2014 | US20140093544 Solid Oral Sensorial Products Including Stain Inhibitor |
| 04/03/2014 | US20140093532 Immunogenic Compositions In Particulate Form And Methods For Producing The Same |
| 04/03/2014 | US20140093523 Anti-Integrin Immunoconjugates, Methods and Uses |
| 04/03/2014 | US20140093522 Bio-orthogonal drug activation |
| 04/03/2014 | US20140093493 Method and formulation for reducing aggregation of a macromolecule under physiological conditions |
| 04/03/2014 | US20140093472 L-histidine in ophthalmic solutions |
| 04/03/2014 | DE102007051059B4 Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen Biomaterial for the controlled release of active ingredients |
| 04/02/2014 | EP2712629A1 Colloid bonded Medicinal Compounds |
| 04/02/2014 | EP2712621A1 Pharmaceutical composition for treating hyperproliferative diseases |
| 04/02/2014 | EP2712614A2 Solvating system and sealant for medical use |
| 04/02/2014 | EP2712611A1 Stabilized aqueous compositions of neuromuscular blocking agents |
| 04/02/2014 | CN1997402B Cytotoxic compounds and conjugates |
| 04/02/2014 | CN103703079A Core-shell microspheres |
| 04/02/2014 | CN103702687A Synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte (CTL) immune responses |
| 04/02/2014 | CN103702686A Methods of preparation of conjugates |
| 04/02/2014 | CN103702668A Composition and method for treatment of diabetes |
| 04/02/2014 | CN103702664A Sustained release tablet comprising pregabalin through two-phase release-controlling system |
| 04/02/2014 | CN103702662A Controlled release peptide formulations |
| 04/02/2014 | CN103702659A Dermal filler compositions including antioxidants |
| 04/02/2014 | CN103702558A Melt processed antimicrobial composition |
| 04/02/2014 | CN103694479A Polymer, glucose-sensitive nanogel, glucose-sensitive drug-loading nanogel and their preparation methods |
| 04/02/2014 | CN103694426A Preparation method of base pair-containing multiple responsive polymer |
| 04/02/2014 | CN103694388A Preparation method and application method for octadecyl methacrylate homopolymer phase-change material, and fever reducing patch |
| 04/02/2014 | CN103694379A Diblock copolymer with light and pH response characteristics and preparation method thereof |
| 04/02/2014 | CN103694375A Novel triterpene-cyclodextrin covalent compound and preparation method and use thereof |
| 04/02/2014 | CN103694357A Preparation and application of novel soluble fusion protein DT390-triTMTP1 |
| 04/02/2014 | CN103693791A Sterile injection water production technique and sterile compressed air preparation method |
| 04/02/2014 | CN103690970A Method for preparing targeting predrug from peat, targeting predrug and application |
| 04/02/2014 | CN103690969A Star anise oil-beta-cyclodextrin inclusion compound, and preparation method and pharmaceutical composition thereof |
| 04/02/2014 | CN103690968A Voriconazole composition and preparation method thereof |
| 04/02/2014 | CN103690967A Autonomous cattle feeding drug carrier and preparation method thereof |
| 04/02/2014 | CN103690966A Self-help-feeding drug carrier for chickens and preparation method thereof |
| 04/02/2014 | CN103690965A Self-help-feeding drug carrier for cats and preparation method thereof |
| 04/02/2014 | CN103690964A Self-help-feeding drug carrier for sheep and preparation method thereof |
| 04/02/2014 | CN103690963A Self-help-feeding drug carrier for horses and preparation method thereof |
| 04/02/2014 | CN103690962A Self-help-feeding drug carrier for dogs and preparation method thereof |
| 04/02/2014 | CN103690961A Intelligent amphiphilic polymer nano micelle and preparation method and application thereof |
| 04/02/2014 | CN103690960A Lomitapide mesylate medicinal composition and preparation method thereof |
| 04/02/2014 | CN103690959A Injectable hollow hydroxyapatite microsphere/chitosan composite drug carrier material and preparation method thereof |
| 04/02/2014 | CN103690958A Insulin preparations containing methionine |
| 04/02/2014 | CN103690957A Glomerular targeted microparticle drug delivery system and preparation method thereof |
| 04/02/2014 | CN103690945A Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 04/02/2014 | CN103690944A Meningitis polysaccharide conjugate vaccine and preparing method thereof |